Edwards Lifesciences Corp. EW
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
Revenue compounded at +6.7% a year over the five years to FY2025.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Each USD of equity produced 11 cents of profit this year.
The 18-year record
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 6.1 | 5.4 | 5.0 | 4.5 | 5.2 | 4.4 | 4.3 | 3.7 | 3.4 | 3.0 | 2.5 | 2.3 | 2.0 | 1.9 | 1.7 | 1.4 | 1.3 | 1.2 |
| Operating income $B | 1.3 | 1.4 | 1.3 | 1.5 | 1.7 | 0.9 | 1.1 | 0.7 | 1.1 | 0.8 | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| EBITDA $B | 1.4 | 1.5 | 1.5 | 1.6 | 1.8 | 1.0 | 1.2 | 0.8 | 1.2 | 0.8 | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Income tax $B | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.5 | 0.2 | 0.1 | 0.3 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 |
| Net income $B | 1.1 | 4.2 | 1.4 | 1.5 | 1.5 | 0.8 | 1.0 | 0.7 | 0.6 | 0.6 | 0.5 | 0.8 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 |
| Free cash flow $B | 1.3 | 0.3 | 0.6 | 1.0 | 1.4 | 0.6 | 0.9 | 0.7 | 0.8 | 0.5 | 0.4 | 0.9 | 0.4 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 |
| EPS, diluted $ | 1.83 | 6.97 | 2.30 | 2.44 | 2.38 | 1.30 | 1.64 | 1.13 | 2.70 | 2.61 | 2.25 | 3.74 | 1.71 | 2.46 | 1.98 | 1.83 | 1.95 | 1.10 |
| Dividend / sh $ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ROE % | 10.6 | 50.2 | 22.5 | 26.1 | 28.9 | 18.9 | 28.7 | 23.7 | 20.9 | 22.2 | 21.1 | 43.4 | 25.8 | 20.9 | 18.0 | 17.7 | 22.5 | 14.7 |
| Shares out B | 0.58 | 0.59 | 0.60 | 0.61 | 0.62 | 0.62 | 0.21 | 0.21 | 0.21 | 0.21 | 0.22 | 0.11 | 0.11 | 0.11 | 0.11 | 0.12 | 0.06 | ◌ |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 18 of the 18 fiscal years we could check. Four checks were skipped: the balance sheet is not tagged before 2009. One check was skipped: EPS is not tagged before 2008. One check was skipped: revenue is not tagged before 2008.